findmyKOL
Clinical trialNCT03921879UnknownPhase 1Interventional

Safety and Efficacy of OT-82 in Participants With Relapsed or Refractory Lymphoma

SponsorOncotartis, Inc.Enrollment50LymphomaLymphoma, B-CellLymphoma, FollicularLymphoma, HodgkinLymphoma, Non-HodgkinLymphoma, Peripheral T-Cell+1 more conditions
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Alabama at Birmingham

    Birmingham, Alabama, United States

    Recruiting
  • City of Hope National Medical Center

    Duarte, California, United States

    Recruiting
  • Sylvester Comprehensive Cancer Center

    Miami, Florida, United States

    Recruiting
  • University of Michigan

    Ann Arbor, Michigan, United States

    Recruiting
  • Roswell Park Cancer Institute

    Buffalo, New York, United States

    Recruiting
  • University Hospitals Seidman Cancer Center

    Cleveland, Ohio, United States

    Recruiting
  • Stephenson Cancer Center

    Oklahoma City, Oklahoma, United States

    Recruiting
  • Thomas Jefferson University Hospital

    Philadelphia, Pennsylvania, United States

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
29 Jul 2019
Primary completion
30 Apr 2021
Completion
30 Jun 2021
Last update posted
23 Oct 2020
Registered enrollment
50
Registry id
NCT03921879

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.